Interactions of elastin and aorta with sugars in vitro and their effects on biochemical and physical properties C. P. WinloveK. H. ParkerA. J. Bailey Originals 01 October 1996 Pages: 1131 - 1139
Differential expression of fructosyllysine-specific receptors on monocytes and macrophages and possible pathophysiological significance R. BrandtC. LandmesserD. Michaelis Originals 01 October 1996 Pages: 1140 - 1147
Hypoglycaemic effect of AICAriboside in mice M. F. VincentM. D. ErionG. Van den Berghe Originals 01 October 1996 Pages: 1148 - 1155
Studies on the influence of insulin on cyclic adenosine monophosphate in human vascular smooth muscle cells: dependence on cyclic guanosine monophosphate and modulation of catecholamine effects M. TrovatiP. MassuccoG. Anfossi Originals 01 October 1996 Pages: 1156 - 1164
Dual function of the intron of the rat insulin I gene in regulation of gene expression A. DamertB. LeibigerI. B. Leibiger Originals 01 October 1996 Pages: 1165 - 1172
Effect of mutations on the sensitivity of human beta-cell glucokinase to liver regulatory protein M. Veiga-da-CunhaL. Z. XuE. Van Schaftingen Originals 01 October 1996 Pages: 1173 - 1179
Insulin action on glucose transport and plasma membrane GLUT4 content in skeletal muscle from patients with NIDDM J. R. ZierathL. HeH. Wallberg-Henriksson Originals 01 October 1996 Pages: 1180 - 1189
PC-1 content in skeletal muscle of non-obese, non-diabetic subjects: relationship to insulin receptor tyrosine kinase and whole body insulin sensitivity L. FrittittaJ. YoungrenI. D. Goldfine Originals 01 October 1996 Pages: 1190 - 1195
Association between HLA and islet cell antibodies in diabetic patients with a mitochondrial DNA mutation at base pair 3243 T. KobayashiY. OkaÅ. Lernmark Originals 01 October 1996 Pages: 1196 - 1200
Decreased insulin action and insulin secretion predict the development of impaired glucose tolerance S. M. HaffnerH. MiettinenM. P. Stern Originals 01 October 1996 Pages: 1201 - 1207
Altered basal and insulin-stimulated phosphotyrosine phosphatase (PTPase) activity in skeletal muscle from NIDDM patients compared with control subjects D. WormJ. VintenH. Beck-Nielsen Originals 01 October 1996 Pages: 1208 - 1214
Mast cells and type VIII collagen in human diabetic nephropathy B. M. RügerQ. HasanT. J. Neale Originals 01 October 1996 Pages: 1215 - 1222
Association of IA-2 autoantibodies with HLA DR4 phenotypes in IDDM S. GenoveseR. BonfantiE. Bonifacio Originals 01 October 1996 Pages: 1223 - 1226
GLP-1 does not acutely affect insulin sensitivity in healthy man L. ØrskovJ. J. HolstO. Schmitz Originals 01 October 1996 Pages: 1227 - 1232
Sequence variations in the human Kir6.2 gene, a subunit of the beta-cell ATP-sensitive K-channel: no association with NIDDM in white caucasian subjects or evidence of abnormal function when expressed in vitro H. SakuraN. WatF. M. Ashcroft Rapid Communication 01 October 1996 Pages: 1233 - 1236
Autoantibodies to IA-2 not detected in NOD mice or BB rats M. G. DeSilvaH. S. JunM. S. Lan Letter To The Editors 01 October 1996 Pages: 1237 - 1238
Mortality of childhood-onset IDDM patients in Estonia T. PodarA. SolntsevR. E. LaPorte Letter To The Editors 01 October 1996 Pages: 1238 - 1239
Abnormal protein redox status in the lens and vitreous of diabetic subjects G. VendemialeI. GrattaglianoE. Altomare Letter To The Editors 01 October 1996 Pages: 1239 - 1240
Glucagon-like peptide-1(7–36) amide and glycogen synthesis in the liver Y. NakagawaK. KawaiK. Yamashita Letter To The Editors 01 October 1996 Pages: 1241 - 1242
Diabetes mellitus and Alzheimer’s disease F. Lithner Letter To The Editors 01 October 1996 Pages: 1242 - 1242
Elevated circulating adhesion molecules in NIDDM — potential mediators in diabetic macroangiopathy P. FaschingW. WaldhäuslO. F. Wagner Letter To The Editors 01 October 1996 Pages: 1242 - 1244
Increased levels of plasma ELAM-1, ICAM-1 and VCAM-1 in NIDDM: possible role of oxidized LDL L. CominaciniU. GarbinV. Lo Cascio Letter To The Editors 01 October 1996 Pages: 1244 - 1244
Erratum to: Troglitazone, an insulin action enhancer, improves metabolic control in NIDDM patients S. KumarA. J. M. Boultonthe Troglitazone study group Erratum 01 October 1996 Pages: 1245 - 1245